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Pleuroparenchymal fibroelastosis (PPFE) is a rare entity that has been recently included in the official American Thoracic
Society/European Respiratory Society (ATS/ERS) statement in 2013 as a group of rare idiopathic interstitial pneumonias (IIPs).
PPFE is characterized by pleural and subpleural parenchymal thickening due to elastic fiber proliferation,mainly in the upper lobes.
The etiology of the disease is unclear, although some cases have been associated as a complication after bonemarrow transplantation,
lung transplantation (LT), chemotherapy, and recurrent respiratory infections. The patients usually report progressive dyspnea
and dry cough and are predisposed to develop spontaneous or iatrogenic pneumothoraces after surgical lung biopsy (SLB)
for its diagnosis. That is why better awareness with the clinical and radiologic features can help optimal management by the
multidisciplinary team. Novel invasive techniques such as cryobiopsy may become useful tools in these patients as it could spare
SLB. We present the first reported cases in Spain.
1. Introduction
Pleuroparenchymal fibroelastosis (PPFE) is a rare condition
that is characterized by fibrosis involving the pleura and
subpleural lung parenchyma, predominantly in the upper
lobes [1, 2]. There is a wide range in age of onset, from young
to old, although in most of the published series it is seen in
adults in their third and fourth decades of life [3]. There is
no gender preponderance [2]. The etiology of the disease is
unclear, although association with different conditions such
as previous chemotherapy treatment, bone marrow and lung
transplantation (LT), and recurrent pulmonary infections
has been described [4–8]. The most common reported
symptoms are dyspnea, nonproductive cough, weight loss,
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and pneumothorax. Thoracic cage deformity “platythorax”
(due to abnormal narrowing of the ratio of the anterior-
posterior diameter of the thorax to the transverse diameter
of the thorax) is a common clinical sign and is an indicator of
disease progression [3, 6].
We present two cases of young adults. In the first case
report, PPFE was not initially suspected. Cryobiopsy was
performed but the findings were inconclusive for diagnosis
since the appropriate histological staining was not requested.
Due to rapid clinical and radiological deterioration evi-
denced by high resolution computed tomography (HRCT),
the suspicion of PPFE was raised leading to pathologists to
perform elastic fiber stain (procedure not routinely done)
on the surgical lung biopsy (SLB). The patient successfully
underwent bilateral lung transplantation (LT) with 24-month
survival up to now.The second case report describes awoman
with previous chemotherapy and radiotherapy treatment for
breast cancer, whose first symptom was spontaneous pneu-
mothorax. Diagnosis was also made by SLB. Both patients
presented with apical pneumothorax as a complication of this
procedure.
2. Case Reports
Case 1. A 25-year-old man referred to our hospital with
six-month progressive dyspnea, asthenia, and nonproduc-
tive cough. His past medical history included childhood
multicentric Castleman’s disease. Diagnosis was achieved by
histological examination of the spleen and local lymph nodes.
He underwent splenectomy and did not present systemic
manifestations or impaired immunity after surgery. He was
diagnosedwith epilepsy 10 years earlier and is currently being
treated with valproic acid 300mg twice daily.The patient was
a lifelong nonsmoker without occupational or environmental
exposures.
The current process begins with a 6-month history of pro-
gressive dyspnea on exertion accompanied by fatigue, daily
dry cough, and weight loss. In the previous year, the patient
presented an episode of acute bronchitis and one month
later he was hospitalized with pneumococcal community-
acquired pneumonia with middle lobe and lingula con-
solidation on the chest X-Ray and positive pneumococcal
antigenuria. 15 days after release from the hospital, a follow-
up chest X-ray showed an interstitial pattern predominantly
in the upper left lobe with bilateral pleural thickening, as
well as loss of both lung volumes (Figure 1(a)). The study was
complemented by HRCT which revealed left apical and right
anterolateral mottled pleural thickening, predominantly in
the left apex (Figure 1(b)). Signs of pulmonary fibrosis were
also observed in the left upper lobe, specially lingula, with the
presence of multiple traction bronchiectasis, gross distortion
of the lung architecture, and ground-glass opacities (Figures
1(c) and 1(d)).
Physical examination revealed low body mass index
(BMI) of 21, flattened thorax, and clubbing with basal
oxygen saturation of 95%. Pulmonary auscultation revealed
hypophonesis without other abnormal respiratory sounds.
Table 1: Anthropometric and functional characteristics of two cases
with pleuropulmonary fibroelastosis.
Case 1 Case 2
Age (yr) 25 40
BMI (m/kg2) 21 19






/FVC (%) 98 75
TLC (L) 4.44 3.22
TLC (%pred) 67 61
IC (L) 1.08 0.77
IC (%pred) 32 31
RV (L) 2.45 1.92
RV (%pred) 150 113
RV/TLC (%) 227 179
IC/TLC ratio 24 23
DLCO (%pred) 49 ND
KCO 88 ND







BMI, body mass index; FVC, forced vital capacity; FEV1, forced expiratory
volume in 1 s; FEV1/FVC, forced expiratory volume in 1 s/forced vital
capacity ratio; TLC, total lung capacity; RV, residual volume; RV/TLC,
residual volume/total lung capacity ratio; IC, inspiratory capacity; IC/TLC,
inspiratory capacity/total lung capacity ratio; DLCO, diffusing capacity for
carbon monoxide; KCO, carbon monoxide transfer coefficient for alveolar
volume; ND: not done; 6MWT, six-minute walk test; SatO2: oxygen
saturation.
The blood analysis showed normal hemogram profile
and renal and hepatic function, but the study of lymphocyte
subpopulations indicates high levels of B cells (CD19 +).
Rheumatoid factor was 49 IU/L (normal value < 14 IU/mL)
and the immunoglobulinMwas 22mg/dL (normal value: 40–
230mg/dL). Severe restrictive pattern and marked reduction
of the carbon monoxide diffusing capacity (DLCO) were
observed in pulmonary function tests (PFT). The carbon
monoxide transfer coefficient (KCO) for alveolar volume
was normal, whereas an increase in the ratio between the
residual volume (RV) and total lung capacity (TLC) was
noted (see Table 1).The analysis of the bronchoalveolar lavage
(BAL) showed 57% macrophages, 28% lymphocytes, 11%
neutrophils, and 1% eosinophil. BAL cellular analysis with
lymphocyte subsets was CD3 80%, CD4 39%, CD 8 27%,
and CD4/CD8 lymphocyte ratio of 1.4 (reference values: 1.6–
1.8). The microbiological analysis of the BAL (culture for
bacteria and fungi, Ziehl-Neelsen stain, silver staining, PCR
mycobacteria, and Lowenstein culture) was negative.
We carried out a transbronchial biopsy using cryoprobe
that showed chronic interstitial inflammatory infiltrates and
areas of interstitial fibrosis. Fiber elastin stain was not
performed.
After 3months, the patient developed progressive clinical
deterioration with hypoxemia and oxygen desaturation dur-
ing a 6-minute walk test (6 MWT) with minimal saturation
of 81%. Therefore, he was treated with supplemental oxygen
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Figure 1: Case 1. (a) Chest radiography shows bilateral pulmonary involvement, with reticular interstitial pattern, withmarked predominance
in the left lung, more prominent on the left and signs of volume loss of both upper lobes with bilateral pleural thickening of apical
predominance. (b) Axial high resolution computed tomography (HRCT) scan obtained through apical region shows pleural thickening,
much more marked in left apex. (c) Axial HRCT scan at level of carina reveals right side marked pleural thickening and signs of pulmonary
fibrosis, mainly in the left upper lobe, with the presence of multiple traction bronchiectasis, superimposed with ground-glass opacities.
(d) Coronal HRCT reformatted image shows left apical and lateral right pleural thickening. Note architectural distortion reflecting fibrotic
changes, accompanied by traction bronchiectasis and scattered peripheral reticular opacities.
and oral corticosteroids (1mg/kg/day with progressive dose
reduction). SLB was performed a month after initiating
the treatment with right apical pneumothorax as a compli-
cation. The biopsy revealed marked subpleural thickening
and homogenous and extensive areas of fibrosis. Dense
elastic fibers were seen in the subpleural area and adjacent
parenchyma on elastic stain (Figure 2). After havingmade the
diagnosis by SLB, it was decided to reexamine the histological
sample from the cryobiopsy and make the Weigert Van
Gieson stain, observing the elastic fibers herein (Figure 3).
The patient underwent bilateral lung transplantation (LT)
at 14 months after diagnosis. Besides pleural fibroelastosis
in the upper lobes (Figure 4), the pathological examination
of the explant describes a pattern of nonspecific interstitial
pneumonia (NSIP) in the lower lobes. Currently, the patient
has 24-month survival after LT.
Case 2. The patient was a 40-year-old female without history
of smoking and with a history of exposure to birds. She
had a history of childhood asthma and a family history of
breast cancer. She was diagnosed at 37 years with bilateral
invasive ductal carcinoma with axillary lymph node metasta-
sis during pregnancy. She received neoadjuvant chemother-
apy before surgery with Adriamycin and cyclophosphamide
followed by docetaxel. She underwent bilateral mastectomy
with dissection of axillary lymph nodes and received adju-
vant chemotherapy with 4 cycles of cyclophosphamide,
methotrexate, and fluorouracil with concomitant radiother-
apy afterwards. The initial chest radiography after the diag-
nosis of breast cancer was normal. However, in the follow-
up chest radiographs, a progressive loss of lung volume at the
expense of the upper lobes was noticed, which manifested by
superior shrinkage and distortion of the pulmonary hila, and
the appearance of coarse irregular linear opacities at higher
fields and biapical pleural thickening with linear opacities of
scar appearance in the neighboring lung parenchyma (see
Figure 5). 15 months after radiotherapy, the patient presented
with acute dyspnea and chest pain. She was diagnosed
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Figure 2: Histological features of Case 1 (surgical lung biopsy specimen). (a) Microscopic image showing sparsely cellular dense connective
tissue with small vessels. Hematoxylin-eosin (HE) 100x. (b) At high power inset in area of dense fibrosis with multiple capillaries, without
inflammatory infiltrate appearance. HE 250x. (c)Microscopic image shows the presence of abundant elastic fibers irregularly grouped. Orcein
stain 100x. (d) Microscopic appearance of the image (b), visualized by fluorescence. Elastic fibers, which shine for eosin autofluorescence, can
be observed. Fluorescence microscopy 250x.
Figure 3: Histopathology of Case 1 (transbronchial cryobiopsy)
showed abundant elastic fibers. Weigert Van Gieson stain 250x.
with right spontaneous pneumothorax that required thorax
drainage.
Subsequently, she presented exertional dyspnea with
ordinary physical activity (NewYorkHeartAssociation Func-
tional Class II) and dry cough, for which she was referred to
our consult for further study.
On physical examination, she had a low BMI of 19, no
acropachy, and diminished global vesicular breath sound.The
chest X-ray showedworsening compared to the previous one,
with apical pleural thickening, hilar retraction, and flattened
thorax on the lateral projection (Figure 5(e)).
The first HRCT performed to this patient 16 months
after diagnosis of breast cancer showed only discrete linear
opacities of fibrotic appearance in both lung apices.
However, the secondHRCT, performedduring the period
inwhich the patient experienced the spontaneous pneumoth-
orax, revealed that the upper linear opacities had progressed
to pulmonary infiltrates of fibrotic appearance. Also evident
was a thickening of the visceral pleura, clearly visible due to
the adjacent pneumothorax (Figure 6). Finally, in a HRCT
made 2 years later, further worsening of biapical infiltrates
with images of honeycombing, appearance of new subpleural
parenchymal consolidations, and greater lung volume loss
with more architectural distortion of the parenchyma were
seen (Figure 7). We performed a thoracic ultrasound (TUS)
in the left hemithorax wall (lateral region from the anterior
axillary line to the posterior axillary line) that showed visceral
pleural thickening (Figure 8).
The BAL fluid revealed 53% macrophages, 43% lympho-
cytes, 2% neutrophils, and 2% eosinophils. The BAL analysis
with lymphocyte subsets showed CD3 75%, CD4 16%, CD 8
60%, and CD4/CD8 lymphocyte ratio of 0.26.
In the blood analysis, the autoimmunity was negative and
serological exams showed positive test results for Aspergillus
and avian precipitins. PFT showed severe restrictive pattern




Figure 4: Case 1. (a) Microscopic examination of explanted lung of Case 1 (right upper lobe). The increase of elastic fibers and abrupt
transition to normal parenchyma is evident. HE 200x. (b) The involved areas show collapse of alveolar spaces by interstitial material that
corresponds to elastic fibers. Scant lymphocyte infiltrate. HE 400x. (c) Van Gieson stain demonstrates abnormal elastic fibers in the thickened
interstitium.
and an increase of the relationship between residual volume
(RV) and TLC (Table 1).The patient underwent breast recon-
struction; therefore, SLB was delayed for sevenmonths. Post-
operatively, she presented another right loculated pneumoth-
orax that resolved spontaneously. The pathology revealed
subpleural parenchymal fibroelastosis with extension into
adjacent alveolar walls predominantly in the upper lobes
(Figures 9 and 10). From an oncological point of view, by
not showing recurrence at 5 years after diagnosis of breast
cancer, the patient was derived to the LT list and pulmonary
rehabilitation with improvement of dyspnea score (NYHA
class I).
3. Discussion
In the updated ATS/ERS classification of idiopathic intersti-
tial pneumonias (IIPs), PPFEhas been specifically introduced
as rare IIPs [1, 2, 6].The information currently available about
this entity comes from case reports that have described the
peculiarities of PPFE.
The cases presented here sharemany of the characteristics
that define the disease. Both are young adults without history
of smoking. The second case had a history of exposure to
avian antigens and showed positive test results for Aspergillus
and avian precipitins, consistent with other reported cases
[5]. Other authors have also reported the presence of other
patterns of interstitial lung disease (ILD) together with the
PPFE such as usual interstitial pneumonia (UIP) and NSIP
[5, 7]. This last pattern was present in the lower lobes in the
explant histological description of our first case.
We cannot assure that the history of childhood’s Castle-
man’s disease of our first case could be a condition associated
with the further development of PPFE. However, the history
of previous respiratory infections and high titers of autoim-
mune markers are consistent with other series [4, 5]. On the
contrary, our second patient was subjected to numerous pre-
cipitating factors such as treatment with cyclophosphamide
and radiation, besides the mentioned exposure to organic
antigens. The development of PPFE after the administration
of these treatments presentswide variability in reported cases,
ranging from 6 months to 16 years [9].
Clinically, the patients presentedwith themost frequently
described “triad”: dyspnea, dry cough, and weight loss. Both
patients were slender with low BMI (slender stature) and flat
rib cage or abnormally narrowed anterior-posterior thoracic
dimension. This last condition has been widely described in
cases from Asian series [3] and has barely been described in
Western patients [6]. Pneumothorax is a common manifes-
tation and can apparently occur at any point in the natural
history of the disease. In the second case, it was the first
symptom of the disease. Besides, both patients had iatrogenic
pneumothorax after performing SLB.The propensity of these
patients to present this complication must be taken into
account in the management of PPFE. The role of other
diagnostic techniques such as transbronchial cryobiopsy had
not been previously described in this entity. However, as
evidenced by our first case, if it had been requested to perform
Orcein or Van Gieson stain (that cause better visualization
of the elastic fibers), the sample would have supported the
diagnosis. This would have avoided the patient to undergo
SLB. This is an important reason to justify knowledge of the
particularities of the disease by the multidisciplinary team
towards its diagnostic approach [9, 10]. The lack of initial
suspicion of PPFE is a fact described in some series, leading to
patients being erroneously classified of other IIPs in the first
place or even having to undergo a second SLB for diagnosis
[10, 11].




Figure 5: Case 2. (a) Initial chest radiograph after the diagnosis of breast cancer and before chemotherapy and radiotherapy treatment was
normal. (b), (c), and (d) Chest radiographs evolution along two-year and two-month interval reveal progressiveworsening. Notice progressive
gradual loss of lung volume at the expense of the upper lobes, which is manifested by superior shrinkage and distortion of the pulmonary hila,
as well as biapical pleural thickening. (e) Lateral chest radiograph shows flattening of the chest, observed by the decreased anteroposterior
diameter of the rib cage (arrow).
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Figure 7: Case 2. (a) Axial HRCT scan shows very discrete lineal opacities in both lung apices. (b) Axial HRCT scan at the same level
compared to (a) two years and two months later shows a loss of volume and prominent parenchymal fibrotic infiltrates. (c) Axial HRCT
image at the level of carina reveals lung architectural distortion, as well as the presence of pleural thickening and subpleural parenchymal
opacities.
Chest ultrasonography or TUS is a useful tool in the
diagnosis and management of many thoracic disorders,
especially in pleural disease. To our knowledge, there is no
information available about TUS in the assessment of PPFE.
Thus, our data indicates that TUSmight be a complementary
imaging modality in the management of this entity and may
help with the differential diagnosis of other ILDs that do not
present pleural involvement.
The impairment of PFT is similar as other IIPs like
idiopathic pulmonary fibrosis (IPF) with restrictive pattern
and reduced DLCO. However, the increase of the ratio of
RV/TLC is a peculiar functional impairment that is not
usually seen in IPF. This finding has been described in other
case reports and was also observed in our patients [12]. This
particular functional feature is derived from the collapse
caused by fibrosis of the upper lobes which can lead to
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Figure 8: Case 2. Thoracic ultrasonography at the level of the middle third of left thorax shows a thick hypoechoic band with fine echoes,
reflecting thickening of the visceral pleura (arrowheads).
(a) (b)
(c) (d)
Figure 9: Surgical lung biopsy of the right upper lobe of Case 2. (a) The alveolar structures are completely obliterated due to accumulation
of elastotic material in the wall. HE 100x. (b) At higher magnification, the presence of a very small lymphocytic infiltration is showed. (c)
Using the Van Gieson stain, the elastotic content of the wall is observed and the alveolar lumen is replaced by connective tissue. (d) Using
autofluorescence, the presence of numerous elastic fibbers is observed in the same field of Figure 9(b).
a compensatory hyperinflation in the lower lobes [3, 12].
Currently, there is no treatment that has proven its efficacy
in this disease. Our second case presented improvement in
exercise tolerance with pulmonary rehabilitation, which is
a nonpharmacological treatment with beneficial results in
other ILDs [13]. As in IIPs, the clinical course depends in
part on the time when the diagnosis is made. This is another
reason to enhance the suspected diagnosis, especially in risk
groups (i.e., after lung or bone marrow transplant or patients
previously treated with chemotherapy). It is also important to
note that, being a disease that may affect young adults, they
have the option of receiving LT, as described in our cases.
In summary, a greater knowledge of the features of this
disease is necessary to increase more accurate diagnosis
and management by the multidisciplinary team. The latest
technical modalities, such as the TUS, could help in the
differential diagnosis of other ILDs. The cryobiopsy can be
a useful tool in the diagnosis as it could potentially minimize
the risk of pneumothorax and achieve an adequate diagnostic
yield of histopathologic assessment.
Case Reports in Pulmonology 9
Figure 10: Case 2. Elastosis areas were sharply defined and showed
an abrupt transition to normal tissue. Van Gieson stain.
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[8] J. H. von der Thüsen, D. M. Hansell, M. Tominaga et al.,
“Pleuroparenchymal fibroelastosis in patients with pulmonary
disease secondary to bone marrow transplantation,” Modern
Pathology, vol. 24, no. 12, pp. 1633–1639, 2011.
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